International Stem Cell Corporation
ISCO
$0.14
-$0.03-15.15%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.39M | 9.20M | 9.09M | 9.09M | 8.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.39M | 9.20M | 9.09M | 9.09M | 8.53M |
| Cost of Revenue | 3.96M | 3.88M | 3.87M | 3.76M | 3.64M |
| Gross Profit | 5.43M | 5.32M | 5.22M | 5.32M | 4.89M |
| SG&A Expenses | 5.06M | 5.10M | 5.10M | 5.17M | 5.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.29M | 9.29M | 9.19M | 9.15M | 9.07M |
| Operating Income | 97.00K | -87.00K | -105.00K | -68.00K | -543.00K |
| Income Before Tax | -59.00K | -241.00K | -251.00K | -209.00K | -678.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.06 | -0.24 | -0.25 | -0.21 | -0.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.00K | -241.00K | -251.00K | -209.00K | -678.00K |
| EBIT | 97.00K | -87.00K | -105.00K | -68.00K | -543.00K |
| EBITDA | 316.00K | 129.00K | 107.00K | 138.00K | -343.00K |
| EPS Basic | -0.02 | -0.04 | -0.04 | -0.03 | -0.07 |
| Normalized Basic EPS | 0.00 | -0.02 | -0.02 | -0.02 | -0.05 |
| EPS Diluted | -0.02 | -0.04 | -0.04 | -0.04 | -0.08 |
| Normalized Diluted EPS | 0.00 | -0.02 | -0.02 | -0.02 | -0.05 |
| Average Basic Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Average Diluted Shares Outstanding | 32.18M | 32.02M | 32.02M | 32.02M | 32.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |